메뉴 건너뛰기




Volumn 20, Issue 2, 2008, Pages 178-184

Double-blind randomized treatment of poststroke depression using nefiracetam

Author keywords

[No Author keywords available]

Indexed keywords

NEFIRACETAM; PLACEBO; 2 PYRROLIDONE DERIVATIVE; PSYCHOTROPIC AGENT;

EID: 85047685693     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2008.20.2.178     Document Type: Article
Times cited : (22)

References (40)
  • 1
    • 0027281068 scopus 로고    scopus 로고
    • Astrom M, Adolfsson R, Asplund K: Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993; 24:976-982
    • Astrom M, Adolfsson R, Asplund K: Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993; 24:976-982
  • 2
    • 0345451666 scopus 로고    scopus 로고
    • Frequency and clinical determinants of poststroke depression
    • Pohjasvaara T, Leppavuori A, Siira I, et al: Frequency and clinical determinants of poststroke depression. Stroke 1998; 29:2311-2317
    • (1998) Stroke , vol.29 , pp. 2311-2317
    • Pohjasvaara, T.1    Leppavuori, A.2    Siira, I.3
  • 3
    • 0025616136 scopus 로고
    • Prevalence and course of depressive disorders in hospitalized stroke patients
    • Morris PLP, Robinson RG, Raphael B: Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatr Med 1990; 20:349-364
    • (1990) Int J Psychiatr Med , vol.20 , pp. 349-364
    • Morris, P.L.P.1    Robinson, R.G.2    Raphael, B.3
  • 4
    • 0037224941 scopus 로고    scopus 로고
    • Cognitive behavioral psychotherapy for depression following stroke: A randomized controlled trial
    • Lincoln NB, Flannaghan T: Cognitive behavioral psychotherapy for depression following stroke: a randomized controlled trial. Stroke 2003; 34:111-115
    • (2003) Stroke , vol.34 , pp. 111-115
    • Lincoln, N.B.1    Flannaghan, T.2
  • 5
    • 0021346860 scopus 로고
    • Nortriptyline treatment of post-stroke depression: A double-blind study
    • Lipsey JR, Robinson RG, Pearlson GD, et al: Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet 1984; 1:297-300
    • (1984) Lancet , vol.1 , pp. 297-300
    • Lipsey, J.R.1    Robinson, R.G.2    Pearlson, G.D.3
  • 6
    • 0033853342 scopus 로고    scopus 로고
    • Fluoxetine in early poststroke depression: A double-blind placebo-controlled study
    • Wiart L, Petit H, Joseph PA, et al: Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000; 31:1829-1832
    • (2000) Stroke , vol.31 , pp. 1829-1832
    • Wiart, L.1    Petit, H.2    Joseph, P.A.3
  • 7
    • 0028232860 scopus 로고
    • Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram
    • Andersen G, Vestergaard K, Lauritzen L: Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25:1099-1104
    • (1994) Stroke , vol.25 , pp. 1099-1104
    • Andersen, G.1    Vestergaard, K.2    Lauritzen, L.3
  • 8
    • 33644875159 scopus 로고    scopus 로고
    • Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: A double-blind, placebo-controlled study
    • Choi-Kwon S, Han SW, Kwon SU, et al: Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006; 37:156-161
    • (2006) Stroke , vol.37 , pp. 156-161
    • Choi-Kwon, S.1    Han, S.W.2    Kwon, S.U.3
  • 11
    • 0022450286 scopus 로고
    • Electroconvulsive therapy for poststroke depression
    • Murray GB, Shea V, Conn DK: Electroconvulsive therapy for poststroke depression. J Clin Psychiatry 1986; 47:258-260
    • (1986) J Clin Psychiatry , vol.47 , pp. 258-260
    • Murray, G.B.1    Shea, V.2    Conn, D.K.3
  • 12
    • 1042289314 scopus 로고    scopus 로고
    • Repetitive transcranial magnetic stimulation as treatment of poststroke depression: A preliminary study
    • Jorge RE, Robinson RG, Tateno A, et al: Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004; 55:398-405
    • (2004) Biol Psychiatry , vol.55 , pp. 398-405
    • Jorge, R.E.1    Robinson, R.G.2    Tateno, A.3
  • 13
    • 0036238117 scopus 로고    scopus 로고
    • Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression
    • Kimura M, Kanetani K, Imai R, et al: Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. Int Clin Psychopharmacol 2002; 17:121-125
    • (2002) Int Clin Psychopharmacol , vol.17 , pp. 121-125
    • Kimura, M.1    Kanetani, K.2    Imai, R.3
  • 14
    • 0028268739 scopus 로고
    • Therapeutic effect of lisuride maleate on post-stroke depression]
    • Japanese
    • Hougaku H, Matsumoto M, Hata R, et al: [Therapeutic effect of lisuride maleate on post-stroke depression]. Nippon Ronen Igakkai Zasshi 1994; 31:52-59 (Japanese)
    • (1994) Nippon Ronen Igakkai Zasshi , vol.31 , pp. 52-59
    • Hougaku, H.1    Matsumoto, M.2    Hata, R.3
  • 15
    • 0041880679 scopus 로고    scopus 로고
    • Comprehensive evaluation of canine renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer
    • Tsuchiya Y, Takahashi Y, Jindo T, et al: Comprehensive evaluation of canine renal papillary necrosis induced by nefiracetam, a neurotransmission enhancer. Eur J Pharmacol 2003; 475:119-128
    • (2003) Eur J Pharmacol , vol.475 , pp. 119-128
    • Tsuchiya, Y.1    Takahashi, Y.2    Jindo, T.3
  • 16
    • 0031914452 scopus 로고    scopus 로고
    • Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways
    • Nishizaki T, Matsuoka T, Nomura T, et al: Nefiracetam modulates acetylcholine receptor currents via two different signal transduction pathways. Mol Pharmacol 1998; 53:1-5
    • (1998) Mol Pharmacol , vol.53 , pp. 1-5
    • Nishizaki, T.1    Matsuoka, T.2    Nomura, T.3
  • 17
    • 27244449904 scopus 로고    scopus 로고
    • Effects of nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats
    • Kitano Y, Komiyama C, Makino M, et al: Effects of nefiracetam, a novel pyrrolidone-type nootropic agent, on the amygdala-kindled seizures in rats. Epilepsia 2005; 46:1561-1568
    • (2005) Epilepsia , vol.46 , pp. 1561-1568
    • Kitano, Y.1    Komiyama, C.2    Makino, M.3
  • 18
    • 0141742496 scopus 로고    scopus 로고
    • Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons
    • Moriguchi S, Marszalec W, Zhao X, et al: Potentiation of N-methyl-D-aspartate-induced currents by the nootropic drug nefiracetam in rat cortical neurons. J Pharmacol Exp Ther 2003; 307:160-167
    • (2003) J Pharmacol Exp Ther , vol.307 , pp. 160-167
    • Moriguchi, S.1    Marszalec, W.2    Zhao, X.3
  • 19
    • 22044437068 scopus 로고    scopus 로고
    • Mechanisms of action of cognitive enhancers on neuroreceptors
    • Narahashi T, Moriguchi S, Zhao X, et al: Mechanisms of action of cognitive enhancers on neuroreceptors. Biol Pharm Bull 2004; 27:1701-1706
    • (2004) Biol Pharm Bull , vol.27 , pp. 1701-1706
    • Narahashi, T.1    Moriguchi, S.2    Zhao, X.3
  • 20
    • 0034931481 scopus 로고    scopus 로고
    • Post-stroke dementia: Nootropic drug modulation of neuronal nicotinic acetylcholine receptors
    • Zhao X, Yeh JZ, Narahashi T: Post-stroke dementia: nootropic drug modulation of neuronal nicotinic acetylcholine receptors. Ann NY Acad Sci 2001; 939:179-186
    • (2001) Ann NY Acad Sci , vol.939 , pp. 179-186
    • Zhao, X.1    Yeh, J.Z.2    Narahashi, T.3
  • 21
    • 12344271062 scopus 로고    scopus 로고
    • Effects of nefiracetam on the levels of brain-derived neurotrophic factor and synapsin I mRNA and protein in the hippocampus of microsphere-embolized rats
    • Ando T, Takagi N, Takagi K, et al: Effects of nefiracetam on the levels of brain-derived neurotrophic factor and synapsin I mRNA and protein in the hippocampus of microsphere-embolized rats. Eur J Pharmacol 2005; 507:49-56
    • (2005) Eur J Pharmacol , vol.507 , pp. 49-56
    • Ando, T.1    Takagi, N.2    Takagi, K.3
  • 22
    • 0036166987 scopus 로고    scopus 로고
    • Nefiracetam improves the impairment of local cerebral blood flow and glucose utilization after chronic focal cerebral ischemia in rats
    • Jin J, Watabe S, Yamamoto T: Nefiracetam improves the impairment of local cerebral blood flow and glucose utilization after chronic focal cerebral ischemia in rats. Pharmacology 2002; 64:119-125
    • (2002) Pharmacology , vol.64 , pp. 119-125
    • Jin, J.1    Watabe, S.2    Yamamoto, T.3
  • 23
    • 0013365108 scopus 로고
    • Clinical utility of DM-9384 (Nefiracetam) in patients with aftereffect following cerebrovascular disorders: A comparative double-blind study with idebenone]
    • Japanese
    • Otomo E, Kogure K, Hirai S, et al: [Clinical utility of DM-9384 (Nefiracetam) in patients with aftereffect following cerebrovascular disorders: a comparative double-blind study with idebenone]. Rinsho Iyaku (J Clin Ther Med) 1994; 10:1871-1918 (Japanese)
    • (1994) Rinsho Iyaku (J Clin Ther Med) , vol.10 , pp. 1871-1918
    • Otomo, E.1    Kogure, K.2    Hirai, S.3
  • 25
    • 0014186152 scopus 로고
    • Development of a rating scale for primary depressive illness
    • Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6:278-296
    • (1967) Br J Soc Clin Psychol , vol.6 , pp. 278-296
    • Hamilton, M.1
  • 26
    • 0020519047 scopus 로고
    • A two-year longitudinal study of post-stroke mood disorders: Findings during the initial evaluation
    • Robinson RG, Starr LB, Kubos KL, et al: A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke 1983; 14:736-744
    • (1983) Stroke , vol.14 , pp. 736-744
    • Robinson, R.G.1    Starr, L.B.2    Kubos, K.L.3
  • 28
  • 29
    • 0037227914 scopus 로고    scopus 로고
    • Poststroke depression: An 18-month follow-up
    • Berg A, Psych L, Palomaki H, et al: Poststroke depression: an 18-month follow-up. Stroke 2003; 34:138-143
    • (2003) Stroke , vol.34 , pp. 138-143
    • Berg, A.1    Psych, L.2    Palomaki, H.3
  • 30
    • 0023194048 scopus 로고
    • The Modified Mini-Mental State (3MS) examination
    • Teng EL, Chui HC: The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48:314-318
    • (1987) J Clin Psychiatry , vol.48 , pp. 314-318
    • Teng, E.L.1    Chui, H.C.2
  • 31
    • 0028970106 scopus 로고
    • Folstein vs modified minimental state examination in geriatric stroke: Stability, validity, and screening utility
    • Grace J, Nadler JD, White DA, et al: Folstein vs modified minimental state examination in geriatric stroke: stability, validity, and screening utility. Arch Neurol 1995; 52:477-484
    • (1995) Arch Neurol , vol.52 , pp. 477-484
    • Grace, J.1    Nadler, J.D.2    White, D.A.3
  • 33
    • 0024328055 scopus 로고
    • Measurements of acute cerebral infarction: A clinical examination scale
    • Brott T, Adams HP, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864-870
    • (1989) Stroke , vol.20 , pp. 864-870
    • Brott, T.1    Adams, H.P.2    Olinger, C.P.3
  • 34
    • 0037811899 scopus 로고    scopus 로고
    • Does cognitive recovery after treatment of poststroke depression last? A 2-year followup of cognitive function associated with poststroke depression
    • Narushima K, Chan KL, Kosier JT, et al: Does cognitive recovery after treatment of poststroke depression last? A 2-year followup of cognitive function associated with poststroke depression. Am J Psychiatry 2003; 160:1157-1162
    • (2003) Am J Psychiatry , vol.160 , pp. 1157-1162
    • Narushima, K.1    Chan, K.L.2    Kosier, J.T.3
  • 35
    • 0035148438 scopus 로고    scopus 로고
    • Improved recovery in activities of daily living associated with remission of post-stroke depression
    • Chemerinski E, Robinson RG, Kosier JT: Improved recovery in activities of daily living associated with remission of post-stroke depression. Stroke 2001; 32:113-117
    • (2001) Stroke , vol.32 , pp. 113-117
    • Chemerinski, E.1    Robinson, R.G.2    Kosier, J.T.3
  • 36
    • 10044271125 scopus 로고    scopus 로고
    • Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials
    • Khan A, Brodhead AE, Kolts RI, et al: Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials. J Psychiatr Res 2005; 39:145-150
    • (2005) J Psychiatr Res , vol.39 , pp. 145-150
    • Khan, A.1    Brodhead, A.E.2    Kolts, R.I.3
  • 37
    • 33748551702 scopus 로고    scopus 로고
    • The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: An extended analysis
    • Lam RW, Andersen HF: The influence of baseline severity on efficacy of escitalopram and citalopram in the treatment of major depressive disorder: an extended analysis. Pharmacopsychiatry 2006; 39:180-184
    • (2006) Pharmacopsychiatry , vol.39 , pp. 180-184
    • Lam, R.W.1    Andersen, H.F.2
  • 38
    • 0037354080 scopus 로고    scopus 로고
    • Early fluoxetine treatment of post-stroke depression: A three-month double-blind placebo-controlled study with an open-label long-term follow up
    • Fruehwald S, Gatterbauer E, Rehak P, et al: Early fluoxetine treatment of post-stroke depression: a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 2003; 250:347-351
    • (2003) J Neurol , vol.250 , pp. 347-351
    • Fruehwald, S.1    Gatterbauer, E.2    Rehak, P.3
  • 39
    • 0034058054 scopus 로고    scopus 로고
    • Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: A placebo controlled, double-blind study
    • Robinson RG, Schultz SK, Castillo C, et al: Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: a placebo controlled, double-blind study. Am J Psychiatry 2000; 157:351-359
    • (2000) Am J Psychiatry , vol.157 , pp. 351-359
    • Robinson, R.G.1    Schultz, S.K.2    Castillo, C.3
  • 40
    • 34250174824 scopus 로고    scopus 로고
    • Relationship between depression severity entry criteria and antidepressant clinical trial outcomes
    • Khan A, Schwartz K, Kolts RL, et al: Relationship between depression severity entry criteria and antidepressant clinical trial outcomes. Biol Psychiatry 2007; 62:65-71
    • (2007) Biol Psychiatry , vol.62 , pp. 65-71
    • Khan, A.1    Schwartz, K.2    Kolts, R.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.